Hudson’s Bay Company (HBC.TO), the Canadian owner of Saks, has approached Macy’s (M) about a potential takeover, people briefed on the matter who were not

Cerulean Pharma (CERU), a clinical-stage company developing nanoparticle-drug conjugates (NDCs), today announced that its Board of Directors is conducting a comprehensive review of strategic alternatives

Frontline (FRO) has approached DHT Holdings (DHT) with a non-binding proposal for a possible business combination where Frontline would acquire all outstanding shares of common